IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomarin Pharmaceutical Inc

CUSIP: 09061GAD3 | 39 institutional holders

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2017

Baker Bros. Advisors LP22,379,000
0.0% of portfolio›$96.0K
UBS Group AG21,000
0.0% of portfolio›$90
Bank of America Corp8,000
0.0% of portfolio›$34
Steward Partners Investment Advisory, LLC5,000
0.0% of portfolio›$21
Royal Bank of Canada2,000
0.0% of portfolio›$9
Wells Fargo & Company1,000
0.0% of portfolio›$4
Bank of Montreal1,000
0.0% of portfolio›$4
StyleTurnoverLocationFiled
Baker Bros. Advisors LP
22,379,000$96.0K0.0%Agg GrowthVery LowNew York, NY2017-05-15
UBS Group AG
21,000$900.0%CoreMediumZurich, Switzerland2017-11-14
Bank of America Corp
8,000$340.0%CoreLowCharlotte, NC2017-05-15
Steward Partners Investment Advisory, LLC
5,000$210.0%CoreLowStamford, CT2017-11-22
Royal Bank of Canada
2,000$90.0%CoreLowToronto, Australia2017-05-15
Wells Fargo & Company
1,000$40.0%CoreLowSan Francisco, CA2017-04-28
Bank of Montreal
1,000$40.0%CoreLowToronto, Australia2017-04-11